更多费用,更多问题:事前授权是全膝关节置换术成本效益医疗的障碍
该前瞻性研究纳入2020至2022年本机构所有商业保险初次全膝关节置换术患者,量化事前授权相关成本。共4289例,2906例(67.8%)需事前授权,1383例(32.2%)不需。需事前授权组术前一年平均费用及从申请到手术日平均费用均更高。
要点
- 初次全膝关节置换术中67.8%患者需事前授权,32.2%不需。
- 需事前授权组术前一年平均费用716±814美元,高于不需组645±688美元(P=0.005)。
- 需事前授权组从申请到手术日平均费用166±238美元,高于不需组85.7±87.9美元(P=0.002)。
核心结论
- 本研究中,初次全膝关节置换术患者获取事前授权反而增加了术前一年及从初始申请日至手术日的费用。
- 未来研究需要更好地理解事前授权审批流程。
研究设计与样本
- 前瞻性研究,纳入2020至2022年本机构所有接受初次全膝关节置换术的商业保险患者。
- 前瞻性收集事前授权状态、获批或拒绝时间、拒绝次数及拒绝原因等数据。
- 记录术前一年及从初始事前授权申请至手术日期间门诊就诊次数和非手术治疗总费用。
主要发现
- 共纳入4289例患者,其中2906例(67.8%)需要事前授权,1383例(32.2%)不需要。
- 需事前授权组术前一年平均费用为716±814美元,不需事前授权组为645±688美元(P=0.005)。
- 需事前授权组从申请日至手术日平均费用为166±238美元,不需事前授权组为85.7±87.9美元(P=0.002)。
- 需事前授权组术前一年主要费用驱动因素为门诊就诊,其次为X线检查。
- 多因素回归显示,任何附录要求使从申请日至手术日的费用增加102美元(P=0.047)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 未来研究需要更好地理解事前授权审批流程。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: While prior authorization (PA) was originally intended to reduce unnecessary healthcare utilization, evidence now suggests that its use results in an increased administrative burden and delayed access to care. To our knowledge, the financial burden and proposed cost-effectiveness of PA in total knee arthroplasty (TKA) are yet to be determined. The purpose of this prospective study was to quantify the costs associated with obtaining PA in primary TKA patients. METHODS: All commercially insured patients undergoing primary TKA from 2020 to 2022 at our institution were included. Data on PA status, time to approval or denial, number of denials, and denial reasons were prospectively collected. Additionally, the number of office visits and overall costs of nonoperative treatment received in the year before TKA and from initial PA request to date of surgery were also recorded. RESULTS: A total of 4,289 patients were included in the analysis. Of these, 2,906 (67.8%) patients required PA and 1,383 (32.2%) did not. Mean cost in the year before TKA was higher in patients who required PA before surgery ($716±814 versus $645±688, P = 0.005). We also found that the mean cost from request date to date of surgery was significantly greater in the PA cohort ($166±238 versus $85.7±87.9, P = 0.002). The main cost drivers in the PA cohort during the year before TKA were office visits followed by x-rays. Upon multivariate regression, any addendum requirement was found to increase costs from the request date to the date of surgery by $102 (P = 0.047). CONCLUSIONS: In the present study, obtaining PA in patients undergoing primary TKA paradoxically increased costs in both the year before TKA and from the initial request date to the date of surgery. Future studies are needed to gain a better understanding of the PA approval process.
引用
- Abe EA, Lizcano JD, Tarabichi S, et al. More Money, More Problems: Prior Authorization Is a Barrier to Cost-Effective Care in Primary Total Knee Arthroplasty. J Arthroplasty. 2025. PMID: 40381962. doi:10.1016/j.arth.2025.05.034
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。